Cargando…
Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis
Background: Immune-related adverse events (irAEs) are inflammatory side effects, which can occur during immune-checkpoint(s) inhibitors (ICIs) therapy. Steroids are the first-line agents to manage irAEs because of their immunosuppressive properties. However, it is still debated whether or when stero...
Autores principales: | Paderi, Agnese, Gambale, Elisabetta, Botteri, Cristina, Giorgione, Roberta, Lavacchi, Daniele, Brugia, Marco, Mazzoni, Francesca, Giommoni, Elisa, Bormioli, Susanna, Amedei, Amedeo, Pillozzi, Serena, Matucci Cerinic, Marco, Antonuzzo, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510096/ https://www.ncbi.nlm.nih.gov/pubmed/34641331 http://dx.doi.org/10.3390/molecules26195789 |
Ejemplares similares
-
Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience
por: Lavacchi, Daniele, et al.
Publicado: (2021) -
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Paderi, Agnese, et al.
Publicado: (2021) -
Systemic Sclerosis Association with Malignancy
por: Lepri, Gemma, et al.
Publicado: (2022) -
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study
por: Paderi, Agnese, et al.
Publicado: (2021) -
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer
por: Lavacchi, Daniele, et al.
Publicado: (2023)